Ormutivimab
Product Specifications
CAS Number
2449086-91-1
Target
Others
Related Pathways
Others
Bioactivity
Ormutivimab (rhRIG), a recombinant human monoclonal antibody designed to target the rabies virus, effectively neutralizes various strains and demonstrates strong efficacy as a post-exposure prophylaxis (PEP) treatment in model studies [1] [2].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1349888-01 0.02 mg (E-Coli)
Recombinant Shewanella sp. 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB)
Sign In for Pricing
View Details MBS1349888-02 0.1 mg (E-Coli)
Recombinant Shewanella sp. 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB)
Sign In for Pricing
View Details 
MBS1349888-03 0.02 mg (Yeast)
Recombinant Shewanella sp. 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB)
Sign In for Pricing
View Details MBS1349888-04 0.1 mg (Yeast)
Recombinant Shewanella sp. 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB)
Sign In for Pricing
View Details MBS1349888-05 0.02 mg (Baculovirus)
Recombinant Shewanella sp. 3,4-dihydroxy-2-butanone 4-phosphate synthase (ribB)
Sign In for Pricing
View Details